DNA

Ginkgo Bioworks Holdings, Inc. [DNA] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

DNA Stock Summary

Top DNA Correlated Resources

DNA

Top 10 Correlated ETFs

DNA

Top 10 Correlated Stocks

DNA

In the News

DNA Financial details

Company Rating
-
Market Cap
2.17B
Income
-892.87M
Revenue
251.46M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.22K
Optionable
No
Shortable
Yes
Earnings
29 Feb 2024
P/E
-3.44
Forward P/E
-
PEG
0.55
P/S
10.16
P/B
2.35
P/C
-
P/FCF
-7.89
Quick Ratio
6.6
Current Ratio
6.78
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.47
EPS next Y
-
EPS next Q
-
EPS this Y
-63.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
41.64%
Revenue last 5Y
35.93%
Revenue Q/Q
-37.3%
EPS Q/Q
-31.25%
-
-
-
-
SMA20
-25%
SMA50
-45.45%
SMA100
-25%
Inst Own
-
Inst Trans
-
ROA
-42%
ROE
-56%
ROC
-0.5%
Gross Margin
75%
Oper. Margin
-292%
Profit Margin
-272%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.993-2.545
52W High
-
52W Low
-
RSI
32
Rel Volume
0.05
Avg Volume
22.47M
Volume
1.16M
Perf Week
-21.35%
Perf Month
-51.01%
Perf Quarter
-29.2%
Perf Half Y
-30.78%
-
-
-
-
Beta
1.357
-
-
Volatility
0.39%, 1.31%
Prev Close
-1.75%
Price
5.6
Change
-2.27%

Something similar

Top by Market Cap
M&M.NS
LLY.DE
TL0.DE
AVGO
BRK-A
Top Correlated ETFs
TECL
BLCN
ARKG
IZRL
PRNT
Top Correlated Stocks
EGHT
SSTK
BTX
DAVA
REKR
Similar Market Cap
1733.TW
8104.TW
TXHPF
BDSCX
1003.HK

Company Profile

Healthcare Biotechnology
  • Volume Average 22.47M
  • Market Capitalization 2.17B
  • Employee 1.22K
  • CEO Dr. Jason Kelly
  • Headquarters Boston,MA,US
  • IPO Date 2021-04-19
  • Website https://www.ginkgobioworks.com

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.